logo

For the Inventor, By the Inventor

New York, NY, United States of America

Irx Therapeutics, Inc.


USPTO Granted Patents = 15

% Expired Patents = 60.0



Forward Citations = 90

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal John W Hadden (12 out of 17 patents)

silverMedal James E Egan (8 out of 13 patents)

bronzeMedal Harvey Brandwein (5 out of 7 patents)

4.  Kathy L Signorelli (4 out of 4 patents)

5.  Martin Kast (2 out of 2 patents)

6.  Paul H Naylor (2 out of 2 patents)

7.  Kathy L Signorelli-Petrat (2 out of 2 patents)

8.  Theresa L Whiteside-Nimick (1 out of 1 patent)

9.  George J Fennington, Jr (1 out of 2 patents)

10.  Theresa L Whiteside (1 out of 1 patent)

11.  Margareta Czystowska (1 out of 1 patent)

12.  Paul Naylor (0 patent)

13.  Harvey J Brandwein (0 patent)


15 patents:

1. 9931378 - Method of immunotherapy for treatment of human papillomavirus infection (2018-04-03),
2. 9789173 - Vaccine immunotherapy for treating cervical cancer in immune suppressed patients (2017-10-17),
3. 9789172 - Vaccine immunotherapy for treating lymphoma in immune suppressed patients (2017-10-17),
4. 9566331 - Vaccine immunotherapy (2017-02-14),
5. 9539320 - Vaccine immunotherapy (2017-01-10),
6. 9492519 - Vaccine immunotherapy (2016-11-15),
7. 9492517 - Vaccine immunotherapy (2016-11-15),
8. 9333238 - Method of immunotherapy for treament of human papillomavirus infection (2016-05-10),
9. 8784796 - Vaccine immunotherapy for treating hepatocellular cancer in immune suppressed patients (2014-07-22),
10. 8591956 - Method of increasing immunological effect (2013-11-26),
11. 8470562 - IRX-2 modified manufacturing process (2013-06-25),
12. 7993660 - Method of increasing immunological effect (2011-08-09),
13. 7182942 - Vaccine immunotherapy for immune suppressed patients (2007-02-27),
14. 7153499 - Vaccine immunotherapy for immune suppressed patients (2006-12-26),
15. 6977072 - Vaccine immunotherapy for immune suppressed patients (2005-12-20),
Company Overview
Irx Therapeutics, Inc. is a biopharmaceutical company based in New York, specializing in the development of innovative therapies for cancer and autoimmune diseases. The organization focuses on harnessing the power of the immune system to create treatments that enhance patient outcomes. With a commitment to advancing medical science, Irx Therapeutics is engaged in cutting-edge research and development, aiming to address unmet medical needs through its proprietary technologies and therapeutic approaches.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

15 Patents

#495 in New York, NY

#1,219 in New York

#21,034 in US

#39,881 in the World

New York, NY (US)
New York, NY, United States of America

Irx Therapeutics, Inc.

Forward Citations = 90

11 inventors:

goldMedal John W Hadden (12 out of 17 patents)

silverMedal James E Egan (8 out of 13 patents)

bronzeMedal Harvey Brandwein (5 out of 7 patents)

4.  Kathy L Signorelli (4 out of 4 patents)

5.  Martin Kast (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Irx Therapeutics, Inc.. Retrieved from https://idiyas.com/company/irx-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…